Stem cell and exosome therapy for spinocerebellar palsy
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a special type of stem cell (neuroinduced mesenchymal stem cells) and their exosomes can safely help people with spinocerebellar palsy. It's an early study focusing on safety and possible improvement in symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of spinocerebellar palsy from a neurologist
- Your symptoms must have started 10 years ago or less
- You must be able to understand and sign a consent form
- You cannot have a serious medical illness or active infection
- You cannot have had cancer in the last 5 years
- You cannot have had stem cell treatment before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cell (from your own body) or tiny particles from those cells (exosomes) can help improve symptoms of Parkinsonism. It's exploring a new way to possibly slow or treat the condition.
This Phase 2 study tests an umbilical cord “stem cell” treatment to improve symptoms in people with spinocerebellar ataxia (a nerve condition that affects balance and walking). It may help walking ability and overall ataxia symptoms, but you must meet specific health and lab safety checks.
This trial tests a stem cell therapy called Stemchymal® for people with a specific type of hereditary ataxia (SCA3). It aims to see if the treatment can improve balance and coordination.
This trial tests a treatment made from stem cell exosomes (tiny particles that may help repair cells) for people with congenital myasthenic syndrome, a muscle-weakening condition. It aims to see if this treatment is safe and could improve symptoms.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
Hear when a new Spinocerebellar Ataxia - All Sub-types trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.